PDLIM7 and neoplasm: αDEC-E1, Adeno–E1-LMP, and the inverse vaccination Adeno–E1-LMP plus αDEC-E1 slowed and inhibited tumor growth when given prophylactically; however, their efficacy differed significantly when given therapeutically.